Income Statement (TTM)
Epitomee Medical Ltd Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|
| Revenue | 10 | 10 | 10 | 10 |
| Change (%) | 0.00 | 0.00 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||
| Change (%) | ||||
| % of Revenue | ||||
| Gross Operating Profit | 10 | 10 | 10 | 10 |
| Change (%) | 0.00 | 0.00 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 3 | 3 | 3 | 3 |
| Change (%) | 10.91 | 9.84 | -0.82 | |
| % of Revenue | 27.86 | 30.90 | 33.94 | 33.66 |
| R&D | 7 | 6 | 6 | 6 |
| Change (%) | -6.78 | -7.27 | -0.82 | |
| % of Revenue | 67.98 | 63.37 | 58.76 | 58.28 |
| OpEx | 17 | 17 | 16 | 2 |
| Change (%) | -0.94 | -0.95 | -86.86 | |
| % of Revenue | 167.63 | 166.06 | 164.49 | 21.62 |
| Operating Income | -7 | -7 | -6 | 8 |
| Change (%) | -2.32 | -2.38 | -221.54 | |
| % of Revenue | -67.63 | -66.06 | -64.49 | 78.38 |
| Interest Expense | -0 | -0 | -0 | |
| Change (%) | -49.12 | -96.55 | ||
| % of Revenue | -0.57 | -0.29 | -0.01 | |
| Net Income | -6 | -6 | -6 | 3 |
| Change (%) | 3.11 | 3.01 | -144.14 | |
| % of Revenue | -56.82 | -58.59 | -60.35 | 26.64 |
Source: Capital IQ
